NDC 0002-2236

Trulicity

Dulaglutide

Trulicity is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Eli Lilly And Company. The primary component is Dulaglutide.

• Product ID: 0002-2236_02015dc8-99de-47b3-b543-5b2a6db567b7
• NDC: 0002-2236
• Product Type: Human Prescription Drug
• Proprietary Name: Trulicity
• Generic Name: Dulaglutide
• Dosage Form: Injection, Solution
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2020-09-03
• Marketing Category: BLA / BLA
• Application Number: BLA125469
• Labeler Name: Eli Lilly and Company
• Substance Name: DULAGLUTIDE
• Active Ingredient Strength: 3 mg/.5mL
• Pharm Classes: GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0002-2236-61

2 SYRINGE in 1 CARTON (0002-2236-61) > .5 mL in 1 SYRINGE

• Marketing Start Date: 2020-09-30
• NDC Exclude Flag: N
• Sample Package?: Y

Drug Details

NDC Crossover Matching brand name "Trulicity" or generic name "Dulaglutide"

NDC	Brand Name	Generic Name
0002-1433	Trulicity	Dulaglutide
0002-1434	Trulicity	Dulaglutide
0002-2236	Trulicity	Dulaglutide
0002-3182	Trulicity	Dulaglutide
50090-3483	Trulicity	Dulaglutide
50090-3484	Trulicity	Trulicity